-
SCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium
10 Dec 2025 13:05 GMT
… for existing and planned pharmaceutical operating companies focused … indicated for:
Treatment of hypertension, to lower blood pressure in … co-administer Arbli™ with aliskiren in patients with diabetes … of prescription drugs to the FDA. Visit www.fda.gov…
-
Anti-Hypertensive Drugs Market CAGR to be at 1.7% from 2025 to 2029 | $40.74 Billion Industry Revenue by 2029
09 Dec 2025 15:45 GMT
… development of new treatments, regulatory alterations … the importance of medication in managing hypertension … Aliskiren
8) By Vasodilators: Hydralazine, Minoxidil
View the full anti-hypertensive drugs … #47;pharmaceuticals-global-market-report
Drugs For …
-
Medications: The 2026 blacklist is causing a stir in prescriptions
03 Dec 2025 06:18 GMT
… treatments well-established in the French pharmaceutical landscape. Certain antidiabetic drugs, … serious infections. In cardiology, aliskiren and dronedarone retain their poor … , domperidone, metopimazine or medicinal clays like Smecta remain criticized …
-
George Medicines presents long-term efficacy and safety data for single pill triple combination therapy for hypertension at American Heart Association’s Scientific Sessions 2025
09 Nov 2025 15:15 GMT
… single pill combination of three medicines: telmisartan, amlodipine and indapamide, for the treatment … aliskiren-containing products with WIDAPLIK if you have diabetes.
Tell your doctor … Pharmaceuticals, Inc. at 1-800-461-7449; or
FDA at: www.fda.gov …
-
SCIENTURE’S Arbli™ Becomes First FDA-Approved Ready-to-Use Liquid Losartan Available Through Major U.S. Wholesalers
16 Oct 2025 13:00 GMT
… FDA-approved ready-to-use liquid losartan formulation accessible through established pharmaceutical … for the treatment of high blood pressure. According … -administer ArbliTM with aliskiren in patients with … prescription drugs to the FDA. Visit www.fda.gov…
-
Rosemont Pharmaceuticals announces FDA Approval of VOSTALLY®(ramipril) Oral Solution for treatment of adult hypertension
31 Jul 2025 19:09 GMT
… Pharmaceuticals announces FDA Approval of VOSTALLY® (ramipril) Oral Solution for the treatment … .S. Food and Drug Administration (FDA) has approved VOSTALLY … co-administer VOSTALLY with aliskiren in patients with … -quality oral liquid medicines to the U. …
-
Piramal Pharma Solutions Supports George Medicines in Developing its New Drug for Hypertension, WIDAPLIK™ (telmisartan, amlodipine and indapamide)
28 Aug 2025 16:34 GMT
… treatment, to lower blood pressure. The U.S. Food and Drug Administration (FDA … failure.
Tell your doctor about all the medicines you take, including … including drug discovery solutions, process and pharmaceutical development services, clinical trial supplies, …
-
Traditional Chinese Medicine Treating Dilated Cardiomyopathy: A Literature Review
07 Aug 2025 14:38 GMT
… focus on randomized controlled trials and mechanistic studies. … the basis of Western medicine treatment, adding Astragalus injection, Danshen … Shenqi Yiqi Dropping Pills, Shexiang Baoxin Pills, Xinshuai Mixture, … .53 The use of aliskiren (a renin inhibitor) …
-
George Medicines Announces FDA Approval of Polypill for Treatment of Hypertension in Adults
11 Jun 2025 01:46 GMT
… phase 3 trials that compared … second trial, after 12 weeks of treatment, blood … -derived drugs), and co-administration with aliskiren restricted … Medicines announces FDA approval of WIDAPLIK™ (telmisartan, amlodipine and indapamide), a new single pill …
-
The Effect of Drug–Drug Interactions on the Pharmacokinetics of Isavuconazole: A Comprehensive Review
17 Jun 2025 13:34 GMT
… cannot achieve stable blood drug concentrations and metabolic … models45,46 overlook concomitant medications as covariates, potentially … treatment of invasive aspergillosis and candidiasis. Eur J Drug … on the pharmacokinetics of aliskiren in healthy subjects. …